Author:
Anca Marietta H.,Giladi Nir,Korczyn Amos D.
Abstract
The effects of treatment with ropinirole (0.25 to 0.5 mg bid) were examined using an open-label design for 8 weeks in 15 subjects with Gilles de la Tourette syndrome (GdlT). All patients completed the study, and most showed an improvement in their tics during treatment. Low-dose ropinirole may improve the motor features in GdlT, but further controlled studies are necessary.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference10 articles.
1. An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries
2. Korczyn AD. Future therapies. In: Kurlan R, ed. The handbook of Tourette’s syndrome and related tic and behavioral disorders. New York: Marcel Dekker, 1993: 481–490.
3. Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's Syndrome
4. Friedhoff AJ. Receptor maturation pathogenesis and treatment of Tourette syndrome. In: Friedhoff AJ, Chase TN, eds. Gilles de la Tourette syndrome. New York: Raven Press, 1982: 133–140.
5. Response to levodopa challenge in Tourette syndrome
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献